Insider Transactions Reported by 17 Insiders of IN8BIO, INC.

Symbol
INAB on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 07 Jan 2025

IN8BIO, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Leslie W. Kreis 10%+ Owner $1,289,996 02 May 2025
Aaron G.L. Fletcher 10%+ Owner $1,289,996 02 May 2025
EMILY FAIRBAIRN Director $999,999 22 Dec 2025
William Ho PRESIDENT AND CEO, Director, 10%+ Owner $189,468 22 Dec 2025
Peter C. Brandt Director $138,226 22 Dec 2025
Alan S. Roemer Director $68,329 22 Dec 2025
Patrick McCall Chief Financial Officer $13,085 22 Dec 2025
Kate Rochlin Chief Operating Officer $12,537 22 Dec 2025
Trishna Goswami Chief Medical Officer $6,931 04 Sep 2024
Melissa Beelen VP, Clinical Operation 29 Jul 2021
Travis Whitfill Director 19 Dec 2024
Luba Greenwood Director 08 May 2025
Bios Equity Partners, LP 10%+ Owner 13 Aug 2021
Bios Clinical Opportunity Fund, LP 10%+ Owner 13 Dec 2023
Jeremy R. Graff Director 08 May 2025
Corinne Epperly Director 08 May 2025
Lawrence Lamb EVP and CSO 27 Apr 2025

Recent Insider Transactions by Companies or Individuals for IN8BIO, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.